Send to:

Choose Destination
See comment in PubMed Commons below
AAPS J. 2010 Mar;12(1):27-32. doi: 10.1208/s12248-009-9156-6. Epub 2009 Nov 17.

Points to consider when establishing drug product specifications for parenteral microspheres.

Author information

  • 1Formulation Development, Alkermes Inc, Cambridge, Massachusetts, USA.


Drug product specifications are a critical element of a good control strategy. Parenteral microsphere products are complex dosage forms, requiring careful development of test methods and acceptance criteria for the specifications. In particular, the in vitro release test method and acceptance criteria require rigorous scientific consideration and should be developed with an eye toward understanding the mechanisms of drug release. The final specifications need to ensure the safety, identity, strength, performance, and quality of the drug product at release and during storage through the end of its shelf-life. The specification limits are typically established based upon regulatory guidance, available data from the manufacturing process (process capability), from non-clinical, clinical, and stability studies.

[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Write to the Help Desk